Odd Lilleng Gammelgaard

20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Odd Lilleng Gammelgaard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 42 Similar Profiles
Bispecific Antibodies Medicine & Life Sciences
Immune System Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences

Research Output 2016 2019

116 Downloads (Pure)

Human cancer evolution in the context of a human immune system in mice

Gammelgaard, O. L., Terp, M. G., Preiss, B. & Ditzel, H. J., Oct 2018, In : Molecular Oncology. 12, 10, p. 1797-1810

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Immune System
Neoplasms
Tumor-Infiltrating Lymphocytes
Ligands
Cell Line

Bispecific antibodies targeting human CD73

Ditzel, H. & Gammelgaard, O. L., 13. Jul 2017, Patent No. WO2017118613 (A1), 13. Jul 2017, Priority date 8. Jan 2016, Priority No. EP20160150669

Research output: Patent

Bispecific Antibodies

Dual epitope targeting of CD73 exhibits potent anti-cancer activity

Gammelgaard, O. L., 23. Oct 2017, p. 1.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Dual epitope targeting of CD73 exhibits potent anti-cancer activity

Gammelgaard, O. L., Terp, M. G., Parren, P. W. H. I., Leth-Larsen, R. & Ditzel, H., 2016.

Research output: Contribution to conference without publisher/journalPosterResearch

Activities 2016 2019

  • 2 Organisation or participation in workshops, courses or seminars
  • 2 Conference presentations
  • 1 Internal examination

AAI Advanced Course in Immunology

Odd Lilleng Gammelgaard (Participant), Nadine Brückmann (Participant)
23. Jul 201728. Jul 2017

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Danish Haematological Research Educational Network, 2017 Annual PhD course: "Immunotherapy in Haematology"

Odd Lilleng Gammelgaard (Participant), Aaraby Nadarajah (Participant), Maria Ormhøj (Participant)
9. Mar 201710. Mar 2017

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Dual epitope targeting of CD73 exhibits potent anti-cancer activity

Odd Lilleng Gammelgaard (Guest lecturer)
29. Apr 2016

Activity: Talks and presentationsConference presentations

Dual Epitope Targeting of CD73 Exhibits Potent Anti-Cancer Activity in TNBC

Odd Lilleng Gammelgaard (Guest lecturer)
4. Feb 2016

Activity: Talks and presentationsConference presentations

Prizes

Metastasis as a systemic disease

Odd Lilleng Gammelgaard (Recipient), 24. Oct 2017

Prize: Prizes, scholarships, distinctions

Årets bedste foredag

Odd Lilleng Gammelgaard (Recipient), 29. Apr 2016

Prize: Prizes, scholarships, distinctions